Inspiremd to report first quarter 2024 financial results and provide corporate business update on tuesday, may 14th

Tel aviv, israel and miami, may 07, 2024 (globe newswire) -- inspiremd, inc. (nasdaq: nspr), developer of the cguard™ embolic prevention stent system (eps) device for the treatment of carotid artery disease and stroke prevention, announced today it will report first quarter 2024 financial results on tuesday, may 14th, before the financial markets open.   management will host a conference call and webcast with the investment community at 8:30 am (edt) that same day to review financial results and provide an update on corporate developments.
NSPR Ratings Summary
NSPR Quant Ranking